WuXi Biologics (Cayman), Inc. (WXXWY)
11.52
-0.21
(-1.79%)
USD |
OTCM |
Oct 29, 16:00
WuXi Biologics Market Cap : 23.65B for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 23.65B |
| October 28, 2026 | 24.08B |
| October 27, 2026 | 23.67B |
| October 26, 2026 | 24.02B |
| October 23, 2026 | 23.71B |
| October 22, 2026 | 23.65B |
| October 21, 2026 | 26.49B |
| October 20, 2026 | 26.24B |
| October 19, 2026 | 25.12B |
| October 16, 2026 | 25.79B |
| October 15, 2026 | 25.66B |
| October 14, 2026 | 25.36B |
| October 13, 2026 | 26.81B |
| October 12, 2026 | 27.82B |
| October 09, 2026 | 28.37B |
| October 08, 2026 | 28.33B |
| October 07, 2026 | 29.63B |
| October 06, 2026 | 30.37B |
| October 05, 2026 | 29.36B |
| October 02, 2026 | 28.64B |
| October 01, 2026 | 29.36B |
| September 30, 2026 | 29.36B |
| September 29, 2026 | 27.96B |
| September 28, 2026 | 28.05B |
| September 25, 2026 | 28.03B |
| Date | Value |
|---|---|
| September 24, 2026 | 27.24B |
| September 23, 2026 | 27.37B |
| September 22, 2026 | 27.61B |
| September 21, 2026 | 28.29B |
| September 18, 2026 | 26.26B |
| September 17, 2026 | 26.36B |
| September 16, 2026 | 26.12B |
| September 15, 2026 | 25.98B |
| September 14, 2026 | 26.12B |
| September 11, 2026 | 24.88B |
| September 10, 2026 | 24.78B |
| September 09, 2026 | 25.27B |
| September 08, 2026 | 26.23B |
| September 04, 2026 | 26.00B |
| September 03, 2026 | 27.04B |
| September 02, 2026 | 26.25B |
| September 01, 2026 | 26.52B |
| August 31, 2026 | 25.77B |
| August 28, 2026 | 26.79B |
| August 27, 2026 | 26.60B |
| August 26, 2026 | 26.75B |
| August 25, 2026 | 26.46B |
| August 24, 2026 | 25.69B |
| August 21, 2026 | 26.75B |
| August 20, 2026 | 26.04B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Austar Lifesciences Ltd. | 10.25M |
| Agilent Technologies, Inc. | 51.08B |
| Bio-Rad Laboratories, Inc. | 10.28B |
| Bruker Corp. | 9.446B |
| Azenta, Inc. | 1.806B |
Market Cap Related Metrics
| PE Ratio | 33.78 |
| PS Ratio | 7.115 |
| PEG Ratio | 0.3231 |
| Price to Free Cash Flow | 38.22 |
| Price | 11.52 |
| Earnings Yield | 2.96% |
| PEGY Ratio | 0.3231 |
| Operating PE Ratio | 21.98 |
| Normalized PE Ratio | 35.99 |